InvestorsHub Logo
Followers 30
Posts 3314
Boards Moderated 0
Alias Born 08/21/2015

Re: misiu143 post# 5622

Sunday, 08/28/2016 8:47:11 AM

Sunday, August 28, 2016 8:47:11 AM

Post# of 233483
No way. $6-7 would give CYDY a market cap well over $500 million or so which is too high for a pre-pivotal trial biotech. IMO, a market cap in the $300 would be reasonable given that pro-140 has great phase 2 results and is currently in two phase 3 trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News